Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4FL8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,048
Award facts
- Contract value 100% obligated
- $15,048.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml formulations, with a ceiling value of $15,048.19. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 16, 2025, and performance occurring at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare systems through its comprehensive pharmaceutical supply portfolio. The company's federal contract awards demonstrate expertise in delivering a wide range of medical products including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This award supports the Defense Health Agency's pharmaceutical supply chain and reflects AmerisourceBergen's established capability to meet federal procurement requirements through competitive selection processes. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts across multiple regions with several contractors, positioning AmerisourceBergen as a key provider within this strategic procurement framework.
Quick answers
Who was awarded contract SPE2DR26F4FL8?
SPE2DR26F4FL8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F4FL8 worth?
The government has obligated $15,048 on SPE2DR26F4FL8.
Is contract SPE2DR26F4FL8 an order under another contract?
Yes. SPE2DR26F4FL8 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4FL8 competed?
The extent of competition for SPE2DR26F4FL8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award